BioSpace News Archive

Business

Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO

Adela, Inc. announced the appointment of Lisa Alderson as Chief Executive Officer, following an extensive, nationwide search.

December 14, 2023
·
3 min read
BioMidwest

CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise

CinFina Pharma, CinRx Pharma’s portfolio company dedicated to expanding treatment options for obesity and metabolic diseases, announced the scientific advisory board members for the company’s multi-asset pipeline.

December 14, 2023
·
5 min read
BioMidwest

Battelle Brings Specialized Engineering Capabilities and Clinical Study Expertise to Collaboration with Spark Biomedical on Department of Defense $1.15 Million Grant

Battelle, the world’s largest independent, non-profit R&D company, and Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technologies are collaborating on the development of a non-invasive device to tackle the harmful effects of Acute Stress Reactions.

December 14, 2023
·
3 min read
Biotech Bay

GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis

GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical company, announces it enters into an out-licensing agreement with Bridge Biotherapeutics for the CXCR4-LPA1 inhibitor combination method of treatment.

December 14, 2023
·
4 min read
Drug Development

CV6 Therapeutics Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial

CV6 Therapeutics announces it has received approval from the UK’s medicines regulator, the MHRA, for the company’s first-in-human Phase 1a clinical trial of its lead oncology therapeutic, CV6-168, in patients with colorectal and other cancers.

December 14, 2023
·
4 min read
Business

Brenus Pharma Joins the Paris Saclay Cancer Cluster (PSCC) to Collaborate at the Heart of Innovation in Oncology

Brenus Pharma has successfully joined the Paris Saclay Cancer Cluster, the first national Onco-cluster.

December 14, 2023
·
1 min read
Pharm Country

Mpox (Monkeypox) Vaccine Triggers Equally Strong Immune Response in Smaller Than Usual Doses and in People With or Without HIV

Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows.

December 14, 2023
·
5 min read
Genetown

Fractyl Health Announces New Pooled Analysis From Revita® Clinical Studies Demonstrating Initial Weight Loss and Sustained Weight Maintenance Without Weight Regain Through at Least One Year Post-Revita Procedure

Fractyl Health presented new weight maintenance data from a pooled analysis of subjects enrolled in Revita clinical studies across the EU and US.

December 14, 2023
·
4 min read
Moolec Science Presents First Quarter Fiscal Year 2024 Business Update

Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year 2024 ended September 30, 2023.

December 14, 2023
·
5 min read
BioCapital

NextCure Provides Year-End Clinical Pipeline Updates

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, provided an update on its clinical pipeline.

December 14, 2023
·
3 min read